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Abstract A20 is a primary response gene which is induced after 
monocyte adherence or cytokine stimulation of a variety of cells. 
The A20 protein belongs to a novel class of Cys2/Cys2 zinc finger 
proteins, and has been characterized as an inhibitor of both 
apoptotic and necrotic cell death. In order to clarify its molecular 
mechanism of action, we used the yeast-based two-hybrid system 
to screen for A20-associated proteins. Here we report that A20 is 
able to self-associate, and demonstrate that the latter interaction 
is mediated by its zinc finger domain. 
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2. Materials and methods 
2.1. Materials 
The yeast expression vectors pAS2 and pGAD424, which encode 
the yeast Gal4 DNA-binding domain (Gal4DB) and the yeast Gal4 
activation domain (GaI4AD), respectively, as well as the Saccharo- 
myces cerevisiae HF7c reporter host strain are contained in the 
Matchmaker two-hybrid system from Clontech Laboratories (Palo 
Alto, CA, USA). Polyclonal antibodies recognizing GaI4DB were ob- 
tained from Upstate Biotechnology (Lake Placid, NY, USA). Alkaline 
phosphatase-conjugated goat anti-rabbit antibodies, 3-amino-l,2,4- 
triazole, 5-bromo-4-chloro-3-indolyl phosphate and nitroblue tetrazo- 
lium were from Sigma Chemical Co. (St. Louis, MO, USA). 5-Bromo- 
4-chloro-3-indolyl-[3-D-galactopyranoside was from Saxon Biochemi- 
cals (Hannover, Germany). 
1. Introduction 
A20 is a primary response gene which was originally iden- 
tified as a cytokine-inducible gene in human umbilical vein 
endothelial cells [1]. Subsequent research demonstrated that 
A20 is not only induced in endothelial cells by bacterial ipo- 
polysaccharide or the cytokines tumor necrosis factor (TNF) 
and interleukin-1, but also by other stimuli in other cell types. 
These include the Epstein-Barr virus LMP1 gene product [2] 
and the B-cell surface receptor CD40 [3] in B-cells, as well as 
the human T-cell leukemia virus type I Tax and phorbol 12- 
myristate 13-acetate [4] in Jurkat cells. Superinduction of the 
A20 gene can often be observed by costimulation with cyclo- 
heximide. Furthermore, A20 is constitutively expressed in 
some cell lines resistant to TNF-mediated cytotoxicity [5], 
suggesting a role for A20 in promoting resistance to TNF-  
induced cell death. This hypothesis was further supported 
by the observation that introduction of the A20 gene in fibro- 
blast cell lines susceptible to TNF-mediated cytotoxicity ren- 
dered the cells resistant to TNF-induced apoptosis [5] or 
TNF-induced necrosis (K. Heyninck, unpublished observa- 
tions). Remarkably, the same gene has been cloned as a 
monocyte adherence cDNA clone, and is therefore also called 
MAD6 [6]. 
The molecular mechanism of action responsible for A20- 
induced cellular resistance to various forms of cell death is 
at present unknown. The human A20 gene encodes a 790 
amino acid-containing protein, consisting of a C-terminal do- 
main with seven Cys2/Cys2 zinc fingers [7]. In accordance with 
several known zinc finger proteins (reviewed in [8]), A20 has 
been postulated to function as a transcriptional activator [7], 
but specific DNA binding has never been demonstrated. Here 
we show that A20 is able to self-associate by its zinc finger 
domain, pointing at a role for the seven Cys2/Cys2 zinc fingers 
in protein-protein i teraction. 
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2.2. Reverse transcriptase PCR cloning of human A20 
Poly(A) + RNA was isolated from MCF7 human breast carcinoma 
cells which had been treated for 4 h with recombinant human TNF 
(1000 IU/ml) and cycloheximide (10 I.tg/ml). Using 0.5 p,g of poly(A) + 
RNA, first-strand cDNA synthesis was catalyzed by Moloney murine 
leukemia virus reverse transcriptase, with a combination of an oligo- 
dT15 primer and a specific antisense primer starting at position 3351 in 
the 3'-untranslated region (5'-AGCTCATGCCCCAACAACAA-3'). 
After RNase H treatment, wo overlapping fragments of A20 were 
amplified in a PCR reaction by Pyrococcusfuriosus DNA polymerase. 
The primer pairs were 5'-GGTATACATATGGCTGAA- 
CAAGTCCTTCC-3'/5'-TGCTCGTCCCCGTCCTGTCC-3' and 5'- 
CGCCCAACTGCCCCTTCTTC-3'/5'-AGCTCATGCCCCAACAA- 
CAA-3'. For subsequent cloning purposes an NdeI site was inserted at 
the start codon in the first primer. The two PCR-amplified cDNAs 
(67-1882 and 1232-3351) were digested by BamHI and ligated at 
position 1614. The whole gene was subsequently cloned as an NdeI- 
XhoI (67 2478) fragment into the prokaryotic expression vector 
pLT10T3 [9]. 
2.3. Construction of two-hybrid fusion vectors 
Gal4DB-A20 and Gal4AD-A20 fusion vectors were constructed by 
in-frame cloning into the yeast expression vectors pAS2 and 
pGAD424, respectively (Fig. 1). The full-length A20 cDNA was 
cloned into vector pAS2 as an NdeI-SalI fragment (hereafter 
pAS2A20), and into vector pGAD424 as an EcoRI-Sall fragment of 
pAS2A20 (hereafter pGAD424A20). 
The C-terminal-deleted A20 cDNA, spanning amino acids 1-367 
and lacking the seven Cys2/Cys2 zinc fingers, was cloned into vector 
pAS2 as an NdeI-blunted Bsp1286I fragment (hereafter 
pAS2A20ZF-), and into vector pGAD424 as an EcoRI-SalI fragment 
of pAS2A20ZF- (hereafter pGAD424A20ZF-). 
The N-terminal-deleted A20 cDNA, spanning amino acids 373-790 
and containing the seven Cys2/Cys2 zinc fingers, was cloned into vec- 
tor pAS2 as an NcoI-XhoI fragment (hereafter pAS2A20ZF+), and 
into vector pGAD424, which was previously modified by cloning an 
NdeI linker with in-frame NcoI site (hereafter pGAD424A20ZF+). 
2.4. Construction of the L929r2 cDNA library 
Poly(A) + RNA was isolated from L929r2 murine fibrosarcoma cells 
[10] which had been treated for 4 h with recombinant murine TNF 
(1000 IU/ml) and cycloheximide (10 ~tg/ml). First-strand cDNA syn- 
thesis was catalyzed by Superscript II reverse transcriptase either with 
oligo-dT15 primers or random primers. The blunted cDNA was li- 
gated to EcoRI adapters and cloned into the pGAD424 yeast expres- 
sion vector. The average insert length was 1400 base pairs. For library 
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Fig. 1. Schematic representation of Gal4-A20 fusion proteins en- 
coded by the respective yeast two-hybrid expression vectors. 
Hatched boxes represent the GaI4DB region (upper three) and the 
Gal4AD region (lower three). Numbers show the in-frame cloned 
A20 fragments. Black segments represent the seven Cys~/Cys2 zinc 
fingers within A20 cDNA. 
screening, >106 individual cDNA inserts were used after pooling of 
both L929r2 library types. 
2.5. Yeast-based two-hybrid screening 
The yeast-based two-hybrid screening was essentially performed as 
described in the manufacturer's directions. Transformation of Gal4- 
A20 fusion vectors in the S. cerevisiae strain HF7c was achieved with 
the lithium acetate method [11]. Transformed cells were grown on 
appropriate synthetic minimal media using Trpl and Leu2 transfor- 
mation markers. Yeast colonies carrying putative interacting proteins 
were selected by growth on synthetic minimal media lacking Trp, Leu 
and His in the presence of 5 mM 3-amino-l,2,4-triazole, and by 
screening for ~-galactosidase (~Gal) activity in a filter assay using 5- 
bromo-4-chloro-3-indolyl-~-D-galactopyranoside s a substrate. Posi- 
tively scoring pGAD424 vectors from the L929r2 cDNA library were 
recovered after electroporation f the plasmid mixtures into the LeuB 
Escherichia coli strain HB 101 and selection on M9 media lacking Leu. 
cDNA inserts encoding candidate A20-associating protein frag- 
ments were sequenced on both strands with a cycle sequencer (Ap- 
plied Biosystems, Foster City, CA, USA). Network BLAST searches 
were conducted using the NCBI on-line service. 
2.6. Detection of Gal4DB-A20 fusion proteins by Western blotting 
Transformation ofpAS2A20, pAS2A20ZF- and pAS2A20ZF + was 
performed in the S. cerevisiae strain HF7c using the lithium acetate 
method [11]. After growth on synthetic minimal medium lacking Trp, 
single colonies were inoculated in 5 ml of the same medium. At 
A600 = 1.5, the yeast protein fraction of the entire culture was separated 
by 10% SDS-polyacrylamide g l electrophoresis and blotted onto a 
nitrocellulose membrane (Schleicher and Schuell, Dassel, Germany). 
Detection of the expressed Gal4DB-A20 fusion proteins was per- 
formed using a polyclonal anti-yeast Gal4DB antibody and an alka- 
line phosphatase-conjugated goatanti-rabbit antibody, with nitroblue 
tetrazolium plus 5-bromo-4-chloro-3-indolyl phosphate as a substrate. 
2. 7. Detection of A2OZF + cDNA by Southern blotting 
L929r2 cDNA inserts encoding candidate A20 interacting proteins 
were obtained by EcoRI digestion of positively scoring pGAD424 
vectors from the L929r2 cDNA library, followed by electrophoresis 
on 1% agarose gel. The DNA was transferred onto Hybond-N nylon 
membrane (Amersham International, Amersham, UK) and hybridized 
with a riP-labeled probe corresponding to the human A20ZF ÷ frag- 
ment (NcoI-XhoI). Hybridization was performed at 60°C in buffer 
containing 5×SSC, 5xDenhardt's olution, 0.5% SDS and 20 I.tg/ 
ml herring sperm DNA. The blot was washed with 2×SSC-0.1% 
SDS at room temperature and subsequently at 60°C. 
3. Results 
3.1. Self-association of  A20 
Screening of a cDNA library for interacting proteins with 
the yeast two-hybrid system requires several initial control 
experiments. In one of these, we tested whether A20 is able 
to self-associate. To this end, the full-length A20 cDNA was 
fused to GaI4DB and Gal4AD in the yeast expression vectors 
pAS2 and pGAD424, respectively (Fig. 1). The S. cerevisiae 
strain HF7c, which contains the His3 and lacZ reporter genes 
under control of a Gal4 promoter, was cotransformed with 
the latter plasmids. Cotransformation of the yeast expression 
vectors pVA3 and pTD 1, which encode the strong interacting 
proteins p53 and SV40 large T-antigen, respectively, served as 
a positive control. Transformed cells were tested for their 
ability to grow on His-deficient plates in the presence of 
5 mM 3-amino-l,2,4-triazole and for the expression of 13Gal 
activity. Interestingly, the latter phenotype was also expressed 
by cells cotransformed with pAS2A20 and pGAD424A20, 
and not by cells which were only transformed with a single 
plasmid or with the empty expression vectors (Table 1). These 
results clearly indicate that A20 is able to self-associate. To 
establish that the self-interaction of A20 is specific, the ability 
of a non-relevant protein to interact with A20 was tested. 
Cotransformation of the S. cerevisiae strain HF7c with 
pAS2A20 and pTDI ,  or with pVA3 and pGAD424A20, did 
not result in His auxotrophy or [3Gal activity, demonstrating 
the specificity of self-association. 
3.2. Self-association of  A20 & mediated by the zinc finger 
domain 
Since the human A20 cDNA encodes a 790 amino acid- 
containing protein consisting of seven Cys2/Cys2 zinc fingers 
in the C-terminal half of the molecule, we investigated 
whether self-association of A20 is mediated by this domain. 
To this end, C-terminal-deleted and N-terminal-deleted A20 
cDNA fragments were fused to Gal4DB (pAS2A20ZF- and 
pAS2A20ZF +, respectively) and Gal4AD (pGAD424A20ZF-  
and pGAD424A20ZF +, respectively). As outlined in Fig. 1, 
A20ZF-  spans amino acids 1-367, and A20ZF + amino acids 
373-790. To ensure that fusion proteins were expressed by 
transformed HF7c cells, extracts were analyzed by Western 
blotting using polyclonal anti-yeast Gal4DB antibodies. The 
latter revealed differentially expressed, but clearly detectable, 
Gal4DB-A20, GaI4DB-A20ZF- and Gal4DB-A20ZF + fusion 
protein levels (Fig. 2). Expression of Gal4AD fusion proteins 
could not be tested because suitable anti-Gal4AD antibodies 
are not available. 
After S. cerevisiae strain HF7c had been cotransformed 
with the yeast expression vectors encoding the A20 deletion 
mutant fusion proteins, the following protein-protein i terac- 
Table 1 
Self-association f A20 
Transformed yeast expression vector(s) Phenotype 
His + 13Gal + 
pAS2 - - 
pAS2A20 - - 
pGAD424 -- - 
pGAD424A20 - - 
pAS2 pGAD424 -- - 
pAS2 pGAD424A20 - - 
pAS2A20 pGAD424 - - 
pAS2A20 pGAD424A20 + + 
pVA3 pTD 1 + + 
pAS2A20 pTD 1 - - 
pVA3 pGAD424A20 -- - 
Survey of His auxotrophy (tested in the presence of 5 mM 3-amino- 
1,2,4-triazole) and [~Gal activity after (co)transformation f S. cere- 
visiae strain HF7c with full-length A20 or control yeast two-hybrid 
expression vectors. (Co)transformation was verified by growth on 
appropriate minimal synthetic media. 
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Fig. 2. Detection of Gal4DB-A20 fusion proteins by Western blot- 
ting. Protein fractions of S. cerevisiae strain HF7c, transformed 
with pAS2 (lane 1), pAS2A20 (lane 2), pAS2A20ZF- (lane 3) or 
pAS2A20ZF + (lane 4), were subjected to SDS-polyacrylamide g l 
electrophoresis and analyzed by Western blotting using anti-Gal4DB 
antibodies. 
tions were revealed by His auxotrophy and ~Gal activity (Ta- 
ble 2): (i) between Gal4DB-A20 and Gal4AD-A20, (ii) be- 
tween Gal4DB-A20ZF + and GaI4AD-A20, and (iii) between 
Gal4DB-A20ZF + and GaI4AD-A20ZF +. No protein-protein 
interaction with any Gal4-A20ZF- fusion protein was ob- 
served. Surprisingly, protein-protein interaction between 
Gal4DB-A20 and Gal4AD-A20ZF + could not be demon- 
strated, which possibly may be ascribed to steric hindrance 
between both fusion proteins under the in vivo conditions 
used. The observations strongly suggest hat self-association 
of A20 is mediated by its zinc finger domain. 
3.3. Screening of  an L929r2 cDNA library for A20 interactions 
confirms association with the zinc finger domain of  A20 
After screening an L929r2 murine fibrosarcoma cDNA li- 
brary with pAS2A20 as a bait, four cDNA inserts encoding 
candidate A20-associating protein fragments were retained. 
Table 2 
Self-association of A20 is mediated by its zinc finger domain 
Transformed yeast expression vectors Phenotype 
His + ~Gal + 
pAS2A20 pGAD424A20 + + 
pAS2A20 pGAD424A20ZF- - - 
pAS2A20 pGAD424A20ZF + - - 
pAS2A20ZF- pGAD424A20 - - 
pAS2A20ZF + pGAD424A20 + + 
pAS2A20ZF- pGAD424A20ZF- - -- 
pAS2A20ZF- pGAD424A20ZF ÷ - - 
pAS2A20ZF + pGAD424A20ZF- - - 
pAS2A20ZF + pGAD424A20ZF + + + 
Survey of His auxotrophy (tested in the presence of 5 mM 3-amino- 
1,2,4-triazole) and ~Gal activity after cotransformation f S. cerevi- 
siae strain HF7c with full-length, C-terminal-deleted or N-terminal- 
deleted A20 yeast two-hybrid expression vectors. Cotransformation 
was verified by growth on appropriate minimal synthetic media. 
Southern blot analysis of these inserts was carried out using 
the human A20ZF + fragment as a probe. Indeed, one of these 
inserts hybridized to the A20ZF + probe, identifying it as an 
A20 fragment (Fig. 3, lane 2). DNA sequencing on both 
strands identified the hybridizing insert as a cDNA insert 
with an open reading frame encoding amino acids 399-775 
of murine A20 [12]. This murine A20 fragment spans the 
second half of the first zinc finger followed by six entire zinc 
fingers, and is almost identical to the human A20ZF + frag- 
ment. The other three cDNA inserts showed no hybridization 
with the human A20ZF + fragment and displayed no sequence 
homology with murine A20. Their identity is being further 
investigated. 
4. Discussion 
Since the abundant Xenopus transcription factor I I IA has 
been reported to contain repeated minidomains with zinc- 
binding property [13], much effort has been made to charac- 
terize the rapidly expanding class of zinc finger proteins (re- 
viewed in [8]). It became clear that independent or adjacent 
zinc fingers can be combined as modules which are able to 
grip specific DNA sequences, and that they are present in 
many transcription factors. Additional research demonstrated 
that protein dimerization often facilitates cooperative high- 
affinity interactions with DNA, resulting in superactivation 
of gene induction. Such protein dimerization can result in 
the formation either of homodimers or of heterodimers. A 
¢e 1 2 3 4  1 2 3 4  
A B 
Fig. 3. Detection of A20ZF + cDNA by Southern blotting. (A) 
Agarose gel electrophoresis of cDNA inserts (lanes 14) after EcoRI 
digestion of positively scoring pGAD424 vectors from an L929r2 
cDNA library. (B) Southern blot analysis of the inserts shown in 
(A), using a s2p-labeled human A20ZF ÷ fragment as a probe. 
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well-established xample is the transcription factor Spl which 
uses Glu-rich regions for self-interaction [14], but the DNA- 
binding zinc finger region for heterotypic interaction with, 
e.g., GATA-1 [15] or RelA(p65) [16]. Self-association of the 
transcription factor GATA-1 is, however, also mediated by its 
DNA-binding zinc finger region [171, and the latter is also 
involved in the interaction with Spl [15] or other members 
of the GATA family of transcription factors [17]. So it has 
become clear that zinc finger regions, which were initially 
thought to be involved in DNA binding, can also mediate 
protein-protein teractions. Alternatively, the LIM domain, 
another zinc finger motif found in at least 40 different pro- 
teins, may be involved in protein-protein teraction, rather 
than in DNA binding ([18], and reviewed in [19]). 
A20 can be considered the first member of a putative novel 
class of zinc finger proteins consisting of a domain with seven 
Cys2/Cys2 zinc fingers with no structural homology to other 
known zinc finger motifs [7]. Although A20 has been exten- 
sively characterized as an inhibitor of apoptotic and necrotic 
cell death, its molecular mechanism of action remains largely 
unknown. Until now, no evidence has been obtained to de- 
monstrate any A20-mediated specific DNA binding. Using the 
yeast-based two-hybrid system to screen for in vivo protein- 
protein interactions [20], we here demonstrate hat A20 is able 
to self-associate. Moreover, using C-terminal-deleted or N- 
terminal-deleted GaI4-A20 fusion proteins, we show that 
A20 self-association is mediated by the zinc finger domain. 
Thus A20 joins the expanding subset of self-associating zinc 
finger proteins. However, besides elf-association, heterotypic 
protein-protein teraction with A20 is likely to occur and is 
under further study. Since A20 negatively regulates its own 
expression, which is mediated by ~cB elements [2,21], a possi- 
ble candidate may be the nuclear transcription factor NF-~:B. 
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